Perspective · 10 Sep 2026
Conference abstractPublished 14 Jun 2018
Biomarkers of T cell responses in allergic diseases
Benaroya Research Institute, USA
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Allergic diseases are complex immunological disorders with multiple cellular and molecular alterations in pathways involving both activation and effector function. To rationally evaluate the mechanistic impact of candidate therapies in these diseases, it is essential to illuminate stages of pathogenesis with the help of informative biomarkers. Specific opportunities to develop correlates of immune mediated disease outcome include inappropriate expansion of pro-inflammatory cells and alterations in gene expression pathways reflecting defective homeostasis. There is now extensive support for the concept that allergen-specific TH2 lymphocytes initiate and drive allergic sensitization. However, a major impediment to the use of allergic diseaseâÂ?Â?causing T cells as both therapeutic targets and clinically useful biomarkers is the lack of an accepted methodology to identify and differentiate these cells from overall nonpathogenic TH2 cell types. We have recently described a proinflammatory human TH2 cell subpopulation that includes all allergen-specific TH2 cells. These cells are terminally differentiated CD4+ T cells characterized by coexpression of CR TH2, CD49d, and CD161 and exhibit numerous functional attributes distinct from conventional TH2 cells. In addition, we demonstrated that these cells are confined to allergic individuals and their disappearance is indicative of clinical responses induced by allergen-specific immunotherapy. Hence, we have denoted these cells with this stable allergic diseaseâÂ?Â?related phenotype as the TH2A cell subset. Further detailed studies focusing on the TH2A cell subset may prove useful in the diagnosis, molecular characterization, or the discovery of novel therapeutic targets to enhance the power of allergen vaccines.
Subjects
Immunology & MicrobiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Clinical and Cellular Immunology.
Commentary · 22 Jul 2026
From Bench to Bedside: Reframing the CXCL13/CXCR5 Axis as a Non-Redundant Organizer of Protective Pulmonary Immunity in COVID-19
Commentary · 17 Jul 2026
CD5L:p40, a third wheel to IL-12 and IL-23 biology?
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Clinical and Cellular Immunology
- SubjectImmunology & Microbiology
- BylineArticles whose byline prints “Erik Wambre”
